[go: up one dir, main page]

BRPI0307816F1 - Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia - Google Patents

Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia

Info

Publication number
BRPI0307816F1
BRPI0307816F1 BRC10307816A BRPI0307816A BRPI0307816F1 BR PI0307816 F1 BRPI0307816 F1 BR PI0307816F1 BR C10307816 A BRC10307816 A BR C10307816A BR PI0307816 A BRPI0307816 A BR PI0307816A BR PI0307816 F1 BRPI0307816 F1 BR PI0307816F1
Authority
BR
Brazil
Prior art keywords
soft capsule
dosage form
oral pharmaceutical
liquid oral
capsule dosage
Prior art date
Application number
BRC10307816A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Madeleine Bohn
Norbert Heintz
Original Assignee
R P Scherer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29715700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0307816(F1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/161,454 external-priority patent/US6890558B2/en
Priority claimed from CA002388431A external-priority patent/CA2388431C/en
Priority claimed from FR0206886A external-priority patent/FR2840203B1/fr
Application filed by R P Scherer Tech Inc filed Critical R P Scherer Tech Inc
Publication of BRPI0307816F1 publication Critical patent/BRPI0307816F1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composição farmacêutica oral para cápsulas macias contendo vinorelbina e método de tratamento. a invenção descrita aqui refere-se a uma composição farmacêutica contendo vinorelbina como um ingrediente ativo que é adequado para encapsulação em cápsulas macias. a composição farmacêutica oral líquida adequada para a composição de carga líquida para uma forma de dosagem de cápsula macia compreende: vinorelbina ou um sal farmaceuticamente aceitável deste; etanol; água; glicerol; e polietileno glicol. na modalidade preferida, a forma de sal de tartarato de vinorelbina é empregada na composição. a invenção também provê um método para tratar câncer compreendendo oralmente administrar, a um paciente em necessidade de tal tratamento, uma cápsula macia compreendendo a composição farmacêutica da invenção.
BRC10307816A 2002-05-31 2006-05-26 Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia BRPI0307816F1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/161,454 US6890558B2 (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
CA002388431A CA2388431C (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
FR0206886A FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement

Publications (1)

Publication Number Publication Date
BRPI0307816F1 true BRPI0307816F1 (pt) 2022-02-15

Family

ID=29715700

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0307816A BRPI0307816B8 (pt) 2002-05-31 2003-05-28 composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia
BRC10307816A BRPI0307816F1 (pt) 2002-05-31 2006-05-26 Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0307816A BRPI0307816B8 (pt) 2002-05-31 2003-05-28 composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia

Country Status (14)

Country Link
EP (1) EP1530459B1 (pt)
JP (2) JP4718170B2 (pt)
CN (1) CN1287794C (pt)
AT (1) ATE462419T1 (pt)
AU (1) AU2003240808B2 (pt)
BR (2) BRPI0307816B8 (pt)
CY (1) CY1110184T1 (pt)
DE (1) DE60331920D1 (pt)
DK (1) DK1530459T3 (pt)
ES (1) ES2343790T3 (pt)
MX (1) MXPA04006054A (pt)
PT (1) PT1530459E (pt)
SI (1) SI1530459T1 (pt)
WO (1) WO2003101383A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1830817T1 (sl) 2004-12-30 2013-04-30 Pierre Fabre Medicament Stabilna disperzija derivata vinka alkaloida v trdnem stanju in postopek njene izdelave
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
CN101134026B (zh) * 2006-08-31 2011-12-07 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
WO2009105937A1 (zh) * 2008-02-29 2009-09-03 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
JP2019508436A (ja) 2016-03-09 2019-03-28 シンバイアス ファーマ アー・ゲー ビノレルビンモノタルトラートおよびその薬学的使用
CN121129791A (zh) * 2025-11-19 2025-12-16 人福普克药业（武汉）有限公司 一种用于抗肿瘤的软胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623629A (en) * 1983-10-31 1986-11-18 Daniel Kerschensteiner Solid-phase immunoassay support and method of use thereof
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
ATE255899T1 (de) * 1999-05-24 2003-12-15 Southern Res Inst Isophosphoramide-senfgasanalogen und deren verwendung

Also Published As

Publication number Publication date
BRPI0307816B8 (pt) 2021-05-25
SI1530459T1 (sl) 2010-08-31
AU2003240808A1 (en) 2003-12-19
ES2343790T3 (es) 2010-08-10
BR0307816C1 (pt) 2006-09-19
BR0307816A (pt) 2005-08-02
WO2003101383A2 (en) 2003-12-11
EP1530459A2 (en) 2005-05-18
EP1530459B1 (en) 2010-03-31
AU2003240808B2 (en) 2008-05-08
ATE462419T1 (de) 2010-04-15
CN1638745A (zh) 2005-07-13
CY1110184T1 (el) 2015-01-14
BRPI0307816B1 (pt) 2018-03-06
HK1079421A1 (en) 2006-04-07
EP1530459A4 (en) 2007-08-22
CN1287794C (zh) 2006-12-06
MXPA04006054A (es) 2004-09-27
WO2003101383A3 (en) 2004-09-30
JP2006516111A (ja) 2006-06-22
JP5334937B2 (ja) 2013-11-06
JP2010280739A (ja) 2010-12-16
JP4718170B2 (ja) 2011-07-06
DK1530459T3 (da) 2010-07-19
PT1530459E (pt) 2010-05-20
DE60331920D1 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
CY1110184T1 (el) Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας
WO2018005695A1 (en) Use of neurokinin-1 antagonists to treat a variety of pruritic conditions
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
ES2180646T3 (es) Formulaciones liquidas orales de alendronato.
US20040258740A1 (en) Transdermal delivery composition
SE9804314D0 (sv) New pharmaceutical formulation
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
CA2434484A1 (en) Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
EP1708685A4 (en) GALENIC FORMS OF EFFERVESCENT ORAL OPIATES AND METHODS OF ADMINISTERING OPIATES
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MX2024015351A (es) Composicion farmaceutica para tratar y resistir a la coagulacion sanguinea y uso de la misma
EP3829572A1 (en) Use of neurokinin-1 antagonists to treat chronic pruritus
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
MXPA04004907A (es) Composiciones de acetaminofen.
RU2020108631A (ru) Новая вспомогательная терапия для применения в способе лечения рака простаты
JP2012041314A5 (pt)
KR20060126555A (ko) 피부학적 연질 겔 조성물
WO2016084099A1 (en) Soft gelatin capsule composition of anti-tussive agents
CA2388431A1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
ES2299738T3 (es) Composicion farmaceutica que combina el tenatoprazol y un antagonista de los receptores h2 a la histamina.
JP2005525391A5 (pt)
RU2004119829A (ru) Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения
DK2091520T3 (da) Oral doseringsform omfattende trisubstituerede glycerol-forbindelser